【单选题】
阅读下面的短文,文中有15处空白,每处空白给出了4个选项,请根据短文的内容从4个选项中选择1个最佳答案。
{{B}} Once-daily PillCould Simplify HIV Treatment{{/B}} Bristol-Myers Squibb and Gilead Sciences have combined many HIV drugs into a single pill. Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and HIV/AIDS, for example, are all treated with {{U}} (51) {{/U}} of drugs.But that can mean a lot of pills to take. It would be {{U}} (52) {{/U}} if drug companies combined all the medicines into a single pill, taken just once a day. Now, two companies say they have done that for people just {{U}} (53) {{/U}} treatment for HIV, the virus that causesAIDS. The companies areBristol-Myers Squibb and Gilead Sciences. They have {{U}} (54) {{/U}} a single pill that combines three drugs currently on the market.Bristol-Myers Squibb sells one of them {{U}} (55) {{/U}} the name of SustivA、Gilead combined the {{U}} (56) {{/U}},Emtriva and Viread, into a single pill in two thousand four. Combining drugs involves more than {{U}} (57) {{/U}} issues. It also involves issues of competition {{U}} (58) {{/U}} the drugs are made by different companies. The new once-daily pill is the result of {{U}} (59) {{/U}}is described as the first joint venture agreement of its kind in the treatment of HIV. In January the NewEngland Journal of Medicine4 published a study of the new pill. Researchers compared its {{U}} (60) {{/U}} to that of the widely used combination of Sustiva andCombivir.Combivir {{U}} (61) {{/U}} two drags,AZT and 3TC、The researchers say that after one year of treatment, the new pill suppressed HIV levels in more patients and with {{U}} (62) {{/U}} side effects. Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine inBaltimore, Maryland, led the research. He is a paid adviser to Gilead andBristol-Meyers Squibb as well as the maker ofCombivir, Glaxo Smith Kline. Glaxo Smith Kline reacted {{U}} (63) {{/U}} the findings by saying that a single study is of limited value. It says the effectiveness ofCombivir has been shown in each of more than fifty studies. The price of the new once-daily pill has not been announceD、But Gilead andBristol-Myers Squibb say they will provide it at reduced cost to developing countries. They plan in the next few months to ask the United States Food andDrugAdministration9 to {{U}} (64) {{/U}} the new pill. There are limits to who could take it because of the different drugs it contains. For example, {{U}} (65) {{/U}} women are told not to take Sustiva because of the risk of birth disorders.Experts say more than forty million people around the world are living with HIV. |
B.with
C.to
D.into
网考网参考答案:C
网考网解析:
react to(“对……作㈩反应”)是固定用法,其他选项均不对。 document.getElementById("warp").style.display="none"; document.getElementById("content").style.display="block"; 查看试题解析出处>>
发布评论 查看全部评论